AAAAAA
Results: 1-25/37
Authors:
STEINMANN A
FRIEDRICH E
RATH U
Citation: A. Steinmann et al., THERAPEUTIC EFFECTS AND TUMOR TARGETING PROPERTIES OF A METHOTREXATE-ALBUMIN-CONJUGATE IN HUMAN-MELANOMA XENO-GRAFTS IN NUDE-MICE, Journal of investigative dermatology, 110(4), 1998, pp. 718-718
Authors:
FAIVRE J
COUILLAULT C
KRONBORG O
RATH U
GIACOSA A
DEOLIVEIRA H
OBRADOR T
OMORAIN C
ANDREATTA R
BUSET M
CRESPON B
FENGER K
JUSTUM AM
KERR G
LEGOUX JL
MARKS C
MATEK W
OWEN RW
PAILLOT B
PIARD F
PIENKOWSKI P
PIGNATELLE M
PRADA A
PUJOL J
ROZEN P
RICHTER F
SEITZ JF
STURNIOLO GC
ZAMBELLI A
Citation: J. Faivre et al., CHEMOPREVENTION OF METACHRONOUS ADENOMAS OF THE LARGE-BOWEL - DESIGN AND INTERIM RESULTS OF A RANDOMIZED TRIAL OF CALCIUM AND FIBER, European journal of cancer prevention, 6(2), 1997, pp. 132-138
Authors:
CUNNINGHAM D
ZALCBERG JR
RATH U
OLIVER I
VANCUTSEM E
SVENSSON C
SEITZ JF
HARPER P
KERR D
PEREZMANGA G
Citation: D. Cunningham et al., FINAL RESULTS OF A RANDOMIZED TRIAL COMPARING TOMUDEX(R) (RALTITREXED) WITH 5-FLUOROURACIL PLUS LEUCOVORIN IN ADVANCED COLORECTAL-CANCER (VOL 7, PG 961, 1996), Annals of oncology, 8(4), 1997, pp. 407-407
Authors:
CUNNINGHAM D
ZALCBERG JR
RATH U
OLVER I
VANCUTSEM E
SVENSSON C
SEITZ JF
HARPER P
KERR D
PEREZMANGA G
AZAB M
SEYMOUR L
LOWERY K
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA (REPRINTED FROM EUROPEAN JOURNAL OF CANCER, VOL 32A, PG 1945-1954, 1995), European journal of cancer, 32A, 1996, pp. 1
Authors:
CUNNINGHAM D
ZALCBERG JR
RATH U
OLIVER I
VANCUTSEM E
SVENSSON C
SEITZ JF
HARPER P
KERR D
PEREZMANGA G
Citation: D. Cunningham et al., FINAL RESULTS OF A RANDOMIZED TRIAL COMPARING TOMUDEX(R) (RALTITREXED) WITH 5-FLUOROURACIL PLUS LEUCOVORIN IN ADVANCED COLORECTAL-CANCER, Annals of oncology, 7(9), 1996, pp. 961-965
Authors:
BOKEMEYER C
KOHRMANN O
TISCHLER J
WEISSBACH L
RATH U
HAUPT A
SCHOFFSKI P
HARSTRICK A
SCHMOLL HJ
Citation: C. Bokemeyer et al., A RANDOMIZED TRIAL OF CISPLATIN, ETOPOSIDE AND BLEOMYCIN (PEB) VERSUSCARBOPLATIN, ETOPOSIDE AND BLEOMYCIN (CEB) FOR PATIENTS WITH GOOD-RISK METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS, Annals of oncology, 7(10), 1996, pp. 1015-1021
Authors:
WILL E
SENNINGER N
OTTO G
MOHLER M
RATH U
THEILMANN L
GUTZLER F
STREMMEL W
Citation: E. Will et al., LIVER-TRANSPLANTATION VS CHEMOTHERAPY WITH R-VERAPAMIL AND DOXORUBICIN - AND THE COMBINATION OF BOTH AS NEOADJUVANT CHEMOTHERAPY IN NONRESECTABLE HEPATOCELLULAR-CARCINOMA, Hepatology, 24(4), 1996, pp. 1888-1888
Authors:
MOHLER M
GUTZLER F
DIMITRAKOPOULOUSTRAUSS A
RATH U
STRAUSS L
STREMMEL W
Citation: M. Mohler et al., PROGNOSIS ASSESSMENT OF TREATED COLORECTAL LIVER METASTATES BY F-18 FU POSITRON EMISSION TOMOGRAPHY (PET), Gastroenterology, 110(4), 1996, pp. 560-560
Authors:
MOHLER M
GUTZLER F
BOHME M
KALLINOWSKI B
RATH U
STREMMEL W
Citation: M. Mohler et al., WEEKLY 48-HOUR-CONTINUOUS 5-FU IN PRETREATED COLORECTAL-CANCER - RESPONSE, SURVIVAL AND QUALITY-OF-LIFE, Gastroenterology, 110(4), 1996, pp. 561-561
Authors:
VANCUTSEM E
CUNNINGHAM D
ZALCBERG J
RATH U
OLVER IN
KERR D
SVENSSON C
SEITZ JF
MANGA GP
HARPER P
LOWERY K
AZAB M
Citation: E. Vancutsem et al., FINAL RESULTS AND SURVIVAL-DATA OF A LARGE RANDOMIZED TRIAL OF ZD1694IN ADVANCED COLORECTAL-CANCER (ACC) CONFIRM COMPARABLE EFFICACY TO 5-FLUOROURACIL PLUS LEUCOVORIN (5FU+LV), Gastroenterology, 110(4), 1996, pp. 608-608
Authors:
STEINMANN A
FRIEDRICH E
RATH U
Citation: A. Steinmann et al., A NOVEL METHOTREXATE-ALBUMIN (MTX-RSA)-CONJUGATE CAUSES SIGNIFICANT GROWTH DELAY OF O-342 OVARIAN-CARCINOMA IN-VIVO, Oncology Reports, 2(1), 1995, pp. 107-109
Authors:
ZALCBERQ J
CUNNINGHAM D
RATH U
OLVER I
KERR D
VANCUTSEM E
SVENSON C
SEITZ JF
HARPER P
Citation: J. Zalcberq et al., TOMUDEX (ZD1694) HAS A HIGHER RESPONSE RATE, SIGNIFICANTLY LESS LEUKOPENIA AND MUCOSITIS AND A SIMPLER DOSING REGIMEN THAN 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) FOR ADVANCED COLORECTAL-CANCER (CRC) - FIRSTRESULTS OF A PHASE-III STUDY, European journal of cancer, 31A, 1995, pp. 701-701
Authors:
CUNNINGHAM D
ZALCBERG JR
RATH U
OLVER I
VANCUTSEM E
SVENSSON C
SEITZ JF
HARPER P
KERR D
PEREZMANGA G
AZAB M
SEYMOUR L
LOWERY K
ACKLAND SP
BASSER RL
CLARKE SJ
GOLDSTEIN D
GREEN MD
GRYGIEL JJ
MCKENDRICK JJ
MILLWARD MJ
OLVER IN
TATTERSALL MHN
THOMSON DB
JAKESZ R
BUSET M
TUENI EA
VANCUTSEM EJD
BAUER J
BESKA F
ADENIS A
BRUNET R
FRANCOIS E
PAILLOT B
ROUGIER P
FINK UFW
KNUTH KRA
KOENIG HJ
BOHME MWJ
WANDER HE
AMADORI D
FRASSINETI L
COCCONI G
PASSALACQUA R
FRIGERIO F
BARNI S
LUPORINI G
LABIANCA R
MARINI G
ZANIBONI A
KLEPP O
TVEIT KM
WIST E
CANDEIAS OFR
GOUVEIA JGP
MARQUES JCN
OLIVEIRA JML
CAVALLI F
DELMORE GD
GOEDHALS L
VOROBIOF DA
ESTEVE AAI
AGUILAR EA
TORRES AA
RUIPEREZ AC
RUBIO ED
SUREDA BM
MANGA GP
ALFONSO PG
GUSTAVSSON B
JEPPSON B
MALMBERG M
STARKHAMMAR H
SVENSSON JH
KEIZER HJ
SCHORNAGEL JH
OBRIEN M
HARPER PG
KERR DJ
SCARFFE JH
TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
Authors:
RUDI J
MULLER M
VONHERBAY A
ZUNA I
RAEDSCH R
STREMMEL W
RATH U
Citation: J. Rudi et al., LACK OF ASSOCIATION OF HELICOBACTER-PYLORI SEROPREVALENCE AND GASTRIC-CANCER IN A POPULATION WITH LOW GASTRIC-CANCER INCIDENCE, Scandinavian journal of gastroenterology, 30(10), 1995, pp. 958-963
Authors:
FAISS S
SCHERUBL H
RATH U
BONATH T
RIECKEN EO
WIEDENMANN B
Citation: S. Faiss et al., HIGH-DOSE LANREOTIDE TREATMENT IN PATIENTS WITH METASTATIC NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS, Gastroenterology, 108(4), 1995, pp. 465-465
Authors:
MOHLER M
DIMITRAKOPOULOUSTRAUSS A
WILL E
STRAUSS L
RATH U
GUTZLER F
Citation: M. Mohler et al., EVALUATION OF CLINICAL-RESPONSE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER BY F-18 FU POSITRON EMISSION TOMOGRAPHY, Gastroenterology, 108(4), 1995, pp. 509-509
Authors:
HORING E
RATH U
RUCKER S
VONGAISBERG U
MEINCKE J
WALENDZIK J
DORR U
BIHL H
Citation: E. Horing et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN THE PRIMARY DIAGNOSIS AND FOLLOW-UP OF GASTRINOMA (ZOLLINGER-ELLISON SYNDROME), Deutsche Medizinische Wochenschrift, 119(11), 1994, pp. 367-374
Authors:
SCHERUBL H
WIEDENMANN B
RIECKEN EO
THOMAS F
BOHME E
RATH U
Citation: H. Scherubl et al., TREATMENT OF THE CARCINOID-SYNDROME WITH A DEPOT FORMULATION OF THE SOMATOSTATIN ANALOG LANREOTIDE, European journal of cancer, 30A(10), 1994, pp. 1590-1591
Authors:
SCHERUBL H
WIEDENMANN B
RIECKEN EO
THOMAS F
BOHME E
RATH U
Citation: H. Scherubl et al., TREATMENT OF THE CARCINOID-SYNDROME WITH A DEPOT FORMULATION OF THE SOMATOSTATIN ANALOG LANREOTIDE, European journal of cancer, 30A(10), 1994, pp. 1590-1591
Authors:
VOLKMANN M
HOFMANN WJ
MULLER M
RATH U
OTTO G
ZENTGRAF H
GALLE PR
Citation: M. Volkmann et al., P53 OVEREXPRESSION IS FREQUENT IN EUROPEAN HEPATOCELLULAR-CARCINOMA AND LARGELY INDEPENDENT OF THE CODON-249 HOT-SPOT MUTATION, Oncogene, 9(1), 1994, pp. 195-204
Authors:
STEINMANN A
FRIEDRICH E
RATH U
Citation: A. Steinmann et al., TUMOR-LOCALIZATION AND THERAPEUTIC EFFICA CY OF NOVEL METHOTREXATE SERUM-ALBUMIN (MTX-HSA) CONJUGATE IN-VIVO, Tumordiagnostik & Therapie, 15(4), 1994, pp. 155-158
Authors:
WILL E
LANGER R
SENNINGER N
THEILMANN L
OTTO G
RATH U
ARNOLD JC
Citation: E. Will et al., NONRESECTABLE HEPATOCELLULAR-CARCINOMA - LIVER-TRANSPLANTATION VS NONSURGICAL TREATMENT, Hepatology, 20(4), 1994, pp. 10000414-10000414
Authors:
MARSCHNER N
KREIENBERG R
SOUCHON R
RATH U
EGGELING B
VOIGTMANN R
RUFFERT K
SCHUTTE M
AMMON A
KESZTYUS T
KAPLAN E
NAGEL G
Citation: N. Marschner et al., EVALUATION OF THE IMPORTANCE AND RELEVANCE OF DOSE INTENSITY USING EPIRUBICIN AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER - INTERIM ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL, Seminars in oncology, 21(1), 1994, pp. 10-16
Authors:
RUDL J
MULLER M
VONHERBAY A
MEYER M
KOMMERELL B
RATH U
Citation: J. Rudl et al., LACK OF ASSOCIATION OF HELICOBACTER-PYLORI INFECTION AND GASTRIC-CANCER IN AN AREA OF LOW GASTRIC-CANCER INCIDENCE AND HIGH SOCIOECONOMIC-STATUS, Gastroenterology, 106(4), 1994, pp. 10000169-10000169
Authors:
MUELLER M
VOLKMAN M
HOFMANN WJ
ZENTGRAF H
RATH U
KOMMERELL B
GALLE PR
Citation: M. Mueller et al., INCREASED STEADY-STATE LEVELS OF WILD-TYPE P53 IN HEPATOMA-CELLS FOLLOWING TREATMENT WITH DOXORUBICIN, Gastroenterology, 106(4), 1994, pp. 10000947-10000947